➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
AstraZeneca
Merck
Boehringer Ingelheim
Dow

Last Updated: January 19, 2021

DrugPatentWatch Database Preview

Litigation Details for BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-03-16 1 . 19. United States Patent No. 7,579,019 (“the ’019 patent”), titled “Pharmaceutical Carrier… a) declare that United States Patent Nos. 7,579,019, 8,147,866, 8,703,177, and 9,522,188 are…A), Defendants infringed United States Patent Nos. 7,579,019, 8,147,866, 8,703,177, and 9,522,188 by …prior to the expiration of United States Patent Nos. 7,579,019, 8,147,866, 8,703,177, and 9,522,188 would…than the expiration date of United States Patent Nos. 7,579,019, 8,147,866, 8,703,177, and 9,522,188, including External link to document
2017-10-12 30 infringement of United States Patent No. 7,579,019 (“the ’019 patent”), United States Patent No. 8,147,866 (“the…’866 patent”), United States Patent No. 8,703,177 (“the ’177 patent”), and United States Patent No. …Court has subject matter jurisdiction over this patent infringement action (the “Action”). Plaintiffs… 9,522,188 (“the ’188 patent”), in connection with Defendants’ submission of Abbreviated New Drug Application… Defendants acknowledge and agree that the Patents-in-Suit are valid, enforceable, and infringed External link to document
2017-03-16 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,019 B2; 8,147,866 B2; 8,703,177…2017 13 October 2017 1:17-cv-00282 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Boehringer Ingelheim
Mallinckrodt
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.